ReviewLife (Basel, Switzerland)2022

Adverse Events of PD-1 or PD-L1 Inhibitors in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis.

Yixi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.